Congratulations to Mike and Tijs who passed their MScPharm vivas at the University of Oxford Department of Pharmacology!
Just out in Nature Chemical Biology!
https://www.nature.com/articles/s41589-019-0310-x
Congratulations to the team at Boehringer Ingelheim and SGC Toronto!
Our latest research featured in JACS.
https://pubs.acs.org/doi/10.1021/jacs.9b02822
Covalent probes can display unmatched potency, selectivity and duration of action; however, their discovery is challenging. In principle, fragments that can irreversibly bind their target can overcome the low affinity that limits reversible fragment screening, but such electrophilic fragments were considered non-selective and were rarely screened. We hypothesized that mild electrophiles might overcome the selectivity challenge and constructed a library of 993 mildly electrophilic fragments. We characterized this library by a new high-throughput thiol-reactivity assay and screened them against ten cysteine-containing proteins. Highly reactive and promiscuous fragments were rare and could be easily eliminated. By contrast, we found hits for most targets. Combining our approach with high-throughput crystallography allowed rapid progression to potent and selective probes for two enzymes, the deubiquitinase OTUB2 and the pyrophosphatase NUDT7. No inhibitors were previously known for either. This study highlights the potential of electrophile-fragment screening as a practical and efficient tool for covalent-ligand discovery.
